Peter Silvera

3.5k total citations
38 papers, 1.6k citations indexed

About

Peter Silvera is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Peter Silvera has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Virology, 26 papers in Immunology and 18 papers in Epidemiology. Recurrent topics in Peter Silvera's work include HIV Research and Treatment (24 papers), Immunotherapy and Immune Responses (15 papers) and Immune Cell Function and Interaction (15 papers). Peter Silvera is often cited by papers focused on HIV Research and Treatment (24 papers), Immunotherapy and Immune Responses (15 papers) and Immune Cell Function and Interaction (15 papers). Peter Silvera collaborates with scholars based in United States, United Kingdom and France. Peter Silvera's co-authors include Mark G. Lewis, Jake Yalley-Ogunro, Aklile Berhanu, Dennis E. Hruby, Douglas W. Grosenbach, Jack Greenhouse, Neil Almond, Karen A. Kent, Franco Lori and Julianna Lisziewicz and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Peter Silvera

38 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Silvera United States 23 1.3k 700 700 544 373 38 1.6k
Clotilde Thiriart Belgium 18 1.2k 0.9× 556 0.8× 660 0.9× 645 1.2× 567 1.5× 23 2.0k
Lennart Åkerblom Sweden 21 820 0.6× 397 0.6× 670 1.0× 527 1.0× 316 0.8× 42 1.5k
José Luis Nájera Spain 21 825 0.6× 590 0.8× 592 0.8× 376 0.7× 187 0.5× 27 1.2k
Peter Rusert Switzerland 22 1.3k 1.0× 268 0.4× 750 1.1× 392 0.7× 622 1.7× 34 1.7k
Yuanzi Hua United States 13 1.1k 0.8× 413 0.6× 398 0.6× 843 1.5× 696 1.9× 14 2.0k
Jeong Hyun Lee United States 22 2.0k 1.5× 715 1.0× 1.2k 1.8× 1.1k 2.1× 687 1.8× 29 2.9k
Brian Gaschen United States 11 1.5k 1.2× 681 1.0× 647 0.9× 768 1.4× 808 2.2× 13 2.3k
Anila Yasmeen United States 19 1.6k 1.2× 352 0.5× 719 1.0× 849 1.6× 533 1.4× 32 2.0k
John W. Balliet United States 18 757 0.6× 632 0.9× 476 0.7× 279 0.5× 380 1.0× 21 1.3k
Maja A. Sommerfelt Norway 17 983 0.7× 403 0.6× 622 0.9× 396 0.7× 548 1.5× 43 1.6k

Countries citing papers authored by Peter Silvera

Since Specialization
Citations

This map shows the geographic impact of Peter Silvera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Silvera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Silvera more than expected).

Fields of papers citing papers by Peter Silvera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Silvera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Silvera. The network helps show where Peter Silvera may publish in the future.

Co-authorship network of co-authors of Peter Silvera

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Silvera. A scholar is included among the top collaborators of Peter Silvera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Silvera. Peter Silvera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Babas, Tahar, et al.. (2012). Protection of Rabbits and Immunodeficient Mice against Lethal Poxvirus Infections by Human Monoclonal Antibodies. PLoS ONE. 7(11). e48706–e48706. 19 indexed citations
3.
Gordon, Shari N., Valentina Cecchinato, Vibeke Andresen, et al.. (2011). Smallpox Vaccine Safety Is Dependent on T Cells and Not B Cells. The Journal of Infectious Diseases. 203(8). 1043–1053. 51 indexed citations
4.
5.
Hirao, Lauren A., Ruxandra Draghia‐Akli, Maria Yang, et al.. (2010). Multivalent Smallpox DNA Vaccine Delivered by Intradermal Electroporation Drives Protective Immunity in Nonhuman Primates Against Lethal Monkeypox Challenge. The Journal of Infectious Diseases. 203(1). 95–102. 85 indexed citations
6.
Buchman, George W., Matthew E. Cohen, Yuhong Xiao, et al.. (2010). A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge. Vaccine. 28(40). 6627–6636. 75 indexed citations
7.
8.
Valentin, Antonio, Priya R. Chikhlikar, Vainav Patel, et al.. (2009). Comparison of DNA vaccines producing HIV-1 Gag and LAMP/Gag chimera in rhesus macaques reveals antigen-specific T-cell responses with distinct phenotypes. Vaccine. 27(35). 4840–4849. 17 indexed citations
9.
Hooper, Jay W., Joseph W. Golden, Peter Silvera, et al.. (2009). Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates. Vaccine. 28(2). 494–511. 54 indexed citations
10.
Megede, Jan zur, Brigitte E. Sanders-Beer, Peter Silvera, et al.. (2008). A Therapeutic SIV DNA Vaccine Elicits T-Cell Immune Responses, but No Sustained Control of Viremia in SIVmac239-Infected Rhesus Macaques. AIDS Research and Human Retroviruses. 24(8). 1103–1116. 18 indexed citations
11.
Nigam, Pragati, Patricia L. Earl, Jeffrey L. Americo, et al.. (2007). DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge. Virology. 366(1). 73–83. 37 indexed citations
12.
Richardson, Max W., Peter Silvera, Jack Greenhouse, et al.. (2004). T-Cell Receptor Excision Circles (TREC) in SHIV 89.6p and SIVmac251 Models of HIV-1 Infection. DNA and Cell Biology. 23(1). 1–13. 12 indexed citations
13.
Quinto, Ileana, Jack Greenhouse, Peter Silvera, et al.. (2004). High Attenuation and Immunogenicity of a Simian Immunodeficiency Virus Expressing a Proteolysis-resistant Inhibitor of NF-κB. Journal of Biological Chemistry. 279(3). 1720–1728. 6 indexed citations
14.
Vahey, Maryanne, et al.. (2003). Patterns of Gene Expression in Peripheral Blood Mononuclear Cells of Rhesus Macaques Infected with SIVmac251 and Exhibiting Differential Rates of Disease Progression. AIDS Research and Human Retroviruses. 19(5). 369–387. 32 indexed citations
15.
Tryniszewska, Elżbieta, János Nacsa, Mark G. Lewis, et al.. (2002). Vaccination of Macaques with Long-Standing SIVmac251 Infection Lowers the Viral Set Point After Cessation of Antiretroviral Therapy. The Journal of Immunology. 169(9). 5347–5357. 79 indexed citations
16.
Richardson, Max W., Peter Silvera, Christelle Capini, et al.. (2002). Immunogenicity of HIV-1 IIIB and SHIV 89.6P Tat and Tat Toxoids in Rhesus Macaques: Induction of Humoral and Cellular Immune Responses. DNA and Cell Biology. 21(9). 637–651. 16 indexed citations
17.
Silvera, Peter, et al.. (2001). Mechanisms of protection induced by live attenuated simian immunodeficiency virus. Journal of Medical Primatology. 30(1). 1–13. 15 indexed citations
18.
Silvera, Peter, Paul Rácz, Norbert Bischofberger, et al.. (2000). Effect of PMPA and PMEA on the Kinetics of Viral Load in Simian Immunodeficiency Virus-Infected Macaques. AIDS Research and Human Retroviruses. 16(8). 791–800. 14 indexed citations
19.
Stebbings, Richard, Jim Stott, Neil Almond, et al.. (1998). Mechanisms of Protection Induced by Attenuated Simian Immunodeficiency Virus II. Lymphocyte Depletion Does Not Abrogate Protection. AIDS Research and Human Retroviruses. 14(13). 1187–1198. 31 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clotilde Thiriart Breakdown of academic impact, for papers by Lennart Åkerblom Breakdown of academic impact, for papers by José Luis Nájera Breakdown of academic impact, for papers by Peter Rusert Breakdown of academic impact, for papers by Yuanzi Hua Breakdown of academic impact, for papers by Jeong Hyun Lee Breakdown of academic impact, for papers by Brian Gaschen Breakdown of academic impact, for papers by Anila Yasmeen Breakdown of academic impact, for papers by John W. Balliet Breakdown of academic impact, for papers by Maja A. Sommerfelt
Rankless by CCL
2026